Converge Bio
Sector: Healthcare & Life Sciences
About Converge Bio
"Bio-AI" generative models that allow pharma companies to design new therapeutic proteins in weeks rather than years.
Products
ConvergeAB™
Antibody design and optimization SaaS-based solution. Support candidate selection, lead optimization and de novo generation across formats like IgG, VHH, scFv and bispecifics. Powered by generative and predictive models, it explores a broad sequence space and ranks candidates by binding, developability and structural fit.